Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology

Publisher: John Wiley & Sons Inc

E-ISSN: 1757-4684|7|4|394-410

ISSN: 1757-4676

Source: EMBO Molecular Medicine, Vol.7, Iss.4, 2015-04, pp. : 394-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content